References
Alshehri AS, El-Kott AF, El-Kenawy AE, Zaki MSA, Morsy K, Ghanem RA, Salem ET, Ebealy ER, Khalifa HS, Altyar AE, AlGwaiz HIM, Ibrahim EH, Mahmoud MS, Dallak MA, Abd-Ella EM (2022) The ameliorative effect of kaempferol against CdCl2- mediated renal damage entails activation of Nrf2 and inhibition of NF-kB. Environ Sci Pollut Res 29:57591–57602. https://doi.org/10.1007/s11356-022-19876-7
Xu C, Huang X, Yan G, Wang D, Hu M, Tang C (2022) Tolvaptan improves contrast-induced acute kidney injury. J Renin-Angiotensin-Aldosterone Syst 2022. https://doi.org/10.1016/j.phrs.2021.105526
Yang X, Feng J, Liang W, Zhu Z, Chen Z, Hu J, Yang D, Ding G (2021) Roles of SIRT6 in kidney disease: a novel therapeutic target. Cell Mol Life Sci 1–19. https://doi.org/10.1007/s00018-021-04061-9
Author information
Authors and Affiliations
Contributions
Eman Casper conceived, revised, and prepared the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The author declares no competing interests.
Additional information
Responsible editor: Philippe Garrigues
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Casper, E. Comments on “The ameliorative effect of kaempferol against CdCl2-mediated renal damage entails activation of Nrf2 and inhibition of NF-kB” by Alshehri Ali et al. (https://doi.org/10.1007/s11356-022–19,876-7). Environ Sci Pollut Res 30, 24790–24791 (2023). https://doi.org/10.1007/s11356-023-25525-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-023-25525-4